GlassScriptPhysician profile
Scott Alexander Harvey
NPI 1457662868
$721.44
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $354 · 2021: $54.91 · 2022: $7.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $250.00 | 2020 | |
| Abbvie INC. | $156.24 | 2019-2021 | |
| Hologic Sales and Service, LLC | $68.13 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.62 | 2019-2020 | |
| Convatec INC. | $51.20 | 2019-2020 | |
| Covidien LP | $28.37 | 2019 | |
| Mallinckrodt Enterprises LLC | $28.35 | 2019 | |
| Coopersurgical, INC. | $21.74 | 2020 | |
| Merck Sharp & Dohme LLC | $19.04 | 2019 | |
| Roche Diagnostics Corporation | $18.50 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.43 | 2019 | |
| Organon LLC | $7.82 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.